Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Milestone payment in IPH 24 project developed in collaboration with Novo Nordisk A/S
February 12, 2009
Innate Pharma SA announces the achievement of a milestone payment in a new monoclonal antibody project developed in collaboration with Novo Nordisk A/S.
| Download Area |
|---|
| PR in english |
| CP en français |